Metal–organic
frameworks (MOFs) with plenty of active sites
and high porosity have been considered as an excellent platform for
the electroreduction of CO2, yet they are still restricted
by the low conductivity or low efficiency. Herein, we insert the electron-conductive
polypyrrole (PPy) molecule into the channel of MOFs through the in
situ polymerization of pyrrole in the pore of MOF-545-Co to increase
the electron-transfer ability of MOF-545-Co and the obtained hybrid
materials present excellent electrocatalytic CO2RR performance.
For example, FECO of PPy@MOF-545-Co can reach up to 98%
at −0.8 V, almost 2 times higher than that of bare MOF-545-Co.
The high performance might be attributed to the incorporation of PPy
that can serve as electric cables in the channel of MOF to facilitate
electron transfer during the CO2RR process. This attempt
might provide new insights to improve the electrocatalytic performance
of MOFs for CO2RR.
For the high-value utilization of tuna liver, the effects of acid-aided (Acid-pH) and alkali-aided pH-shifting (Alkali-pH) on the physicochemical and functional properties of the protein powder prepared by pH-shifting and freeze-drying were studied. As expected, the protein powder with high purity could be obtained through Acid-pH or Alkali-pH followed by freeze drying, while the Alkali-pH led to a higher protein yield, higher protein ratio, lower lipid ratio and lower heavy metal content than Acid-pH. The amino acid profile of the protein powder prepared by Alkali-pH (Alkali-PP) was similar with that prepared by Acid-pH (Acid-PP). In addition, compared with Acid-PP, the Alkali-PP possessed the greater capacities in emulsion activity, foaming capacity and fat absorption capacity. Furthermore, the foaming capacity, foam stability and fat absorption capacity of Alkali-PP was better than soy protein powder. Therefore, Alkali-pH followed by freeze-drying would be a better alternative to prepare high-quality protein powder from tuna liver in the food industry.
Visible-light triggered drug delivery system based on tetra-ortho-methoxy-substituted azobenzene (mAzo) and β-cyclodextrin (β-CD) modified mesoporous silica nanoparticles (MSNs-CD).
The efficient CO2 electroreduction into high‐value products largely relies on the CO2 adsorption/activation or electron‐transfer of electrocatalysts, thus site‐specific functionalization methods that enable boosted related interactions of electrocatalysts are much desired. Here, an oriented coordination strategy is reported to introduce N‐rich auxiliary (i.e., hexamethylenetetramine, HMTA) into metalloporphyrin metal organic frameworks (MOFs) to synthesize a series of site‐specific functionalized electrocatalysts (HMTA@MOF‐545‐M, M = Fe, Co, and Ni) and they are successfully applied in light‐assisted CO2 electroreduction. Noteworthy, thus‐obtained HMTA@MOF‐545‐Co presents approximately two times enhanced CO2 adsorption‐enthalpy and electrochemical active surface‐area with largely decreased impedance‐value after modification, resulting in almost twice higher CO2 electroreduction performance than its unmodified counterpart. Besides, its CO2 electroreduction performance can be further improved under light‐illumination and displays superior FECO (≈100%), high CO generation rate (≈5.11 mol m−2 h−1 at −1.1 V) and energy efficiency (≈70% at −0.7 V). Theoretical calculations verify that the oriented coordination of HMTA can increase the charge density of active sites, almost doubly enhance the CO2 adsorption energy, and largely reduce the energy barrier of rate determining step for the boosted performance improvement. This work might promote the development of modifiable porous crystalline electrocatalysts in high‐efficiency CO2 electroreduction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.